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The melanocortin-1 receptor (MC1R) is a key regulator of mammalian pigmentation. Melanism in
the grey squirrel is associated with an eight amino acid deletion in the mutant melanocortin-1
receptor with 24 base pair deletion (MC1RD24) variant. We demonstrate that the MC1RD24 exhibits
a higher basal activity than the wildtype MC1R (MC1R-wt). We demonstrate that agouti signalling
protein (ASIP) is an inverse agonist to the MC1R-wt but is an agonist to the MC1RD24. We conclude
that the deletion in the MC1RD24 leads to a receptor with a high basal activity which is further acti-
vated by ASIP. This is the ﬁrst report of ASIP acting as an agonist to MC1R.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction receptor (MC1R) and the agouti encodes the agouti signallingAnimal pigmentation is often dramatic and strikingly beautiful
and has many functions including thermoregulation, crypsis,
protection and signalling [1–7].
Colouration is determined by the type, amount and distribution
of melanin pigments, which are produced in melanocytes found in
hair follicles of the epidermis. Mammals produce two distinct
melanins, phaeomelanin which is red/yellow and eumelanin which
is brown/black [8]. Protein products of the extension and agouti loci
have been identiﬁed as key regulators in the production of these
two pigments. The extension locus encodes the melanocortin-1protein (ASIP).
The MC1R is a seven transmembrane G protein-coupled recep-
tor (GPCR) predominantly expressed in melanocytes. This receptor
has a high basal level of ligand-independent constitutive activity;
however the receptor is activated further by its agonist a-melano-
cyte stimulating hormone (a-MSH) [9–11]. a-MSH is a small pep-
tide secreted by the pituitary gland where it is cleaved from the
precursor, pro-opiomelanocortin (POMC). a-MSH is also produced
by keratinocytes in the epidermis [12]. Activation of the MC1R
leads to raised intracellular levels of cAMP by coupling to adenyl-
ate cyclase activity [13,14]. High cAMP levels lead to several signal-
ling cascades including changes in gene expression via the cAMP
responsive element binding protein (CREB) family of transcription
factors [15]. Intracellular cAMP levels are pivotal in determining
the switch from eumelanin to phaeomelanin production. Basal
levels of cAMP from unstimulated receptors are sufﬁcient to
stimulate the expression of the gene encoding tyrosinase which
is the rate limiting enzyme required for the production of both
eumelanin and phaeomelanin [16]. Lower levels of cAMP reduce
the expression of genes encoding tyrosinase-related protein 1
(TRP-1) and dopachrome tautomerase (DCT) which are required
for eumelanogenesis but not phaeomelanogenesis. Raised cAMP
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dendricity and increased proliferation with the overall effect of
increased eumelanogenesis [17–19]. ASIP is a 131 residue peptide
produced by dermal papillae cells where it acts in a paracrine fash-
ion on follicular melanocytes. In humans and mice, ASIP acts as a
high afﬁnity inverse agonist of the MC1R, inhibiting binding of
the agonist a-MSH and inactivating the receptor [20,21]. Inactiva-
tion of the receptor leads to a fall in cAMP levels and a switch to
phaeomelanogenesis and ultimately, cessation of pigment produc-
tion [22,23]. In this way ASIP acts with the MC1R to form a revers-
ible switch determining which type of melanin is synthesised.
Cyclical ‘‘off’’ and ‘‘on’’ switching of MC1R receptor by ASIP is
needed to produce hairs with distinctive banding patterns found
in wildtype agouti mice.
Wildtype agouti mice produce hairs which are black at the tips
and base but contain a yellow subapical band. This band corre-
sponds to a switch from eumelanin to phaeomelanin synthesis
which is caused by a pulse of ASIP expression in the hair follicle
during day four to six of the hair growth cycle. When this transient
ASIP expression stops, eumelanogenesis resumes [20]. The wild-
type grey squirrel (Sciurus carolinensis) also produces banded hairs,
having a white tip, a band of black and then an orange base [24].
Melanism in the grey squirrel is associated with an eight amino
acid deletion in the MC1R [24]. The grey phenotype is homozygous
for the MC1R-wt E+ allele and the jet black phenotype is homozy-
gous for the MC1RD24 EB allele. Jet black squirrels have no agouti
banding, and produce only solid black hairs (Supplementary mate-
rial S1).
In this study we report how the MC1R of wildtype and melanic
squirrels respond to a-MSH and ASIP in transfected cell models.
The results demonstrate that the eight amino acid deletion in the
MC1R of the melanic grey squirrel leads to a receptor with a high
basal level of activity which can be further activated by a-MSH.
We also demonstrate that ASIP acts as an agonist instead of an
inverse agonist to the MC1RD24 melanic variant and offer a work-
ing hypothesis as to how structural changes caused by this deletion
may lead to the observed changes in activity.
2. Materials and methods
2.1. DNA constructs
Genomic DNA was extracted from muscle tissue of wildtype
and jet black squirrels using a Qiagen blood and tissue kit following
the manufacturer’s instructions. The entire coding sequences of the
wildtype MC1R-wt E+ (accession number EU604831.2) and mutant
MC1RD24 EB (accession number EU604830.3) genes were ampliﬁed
by PCR in a total volume of 25 ll using approximately 25 ng
template DNA, 3 mM MgCl2, 0.2 mM dNTPs, 0.4 lM primers, and
0.1 ll Taq polymerase using the following PCR parameters: initial
denaturation 94 C for 2 min followed by 35 cycles of 94 C for
30 s, 68 C for 30 s, and 72 C for 5 min. The ﬁnal extension step
was performed at 72 C for 30 min. The following primers were
used (start codon underlined and stop codon removed in the
position indicated by the vertical line) MC1Rexpf1 50-CAC-
CATGGCTGTACAGAGGAGGCTCC-30, MC1Rexpr1 50-C | CCAGGAG-
CACAGCAGCACCTCC-30. PCR products were cloned into a
pcDNA3.1/CT-GFP-TOPO Invitrogen expression vector such that
the genes were tagged with GFP on the C terminus. Constructs
were veriﬁed by complete sequencing.
2.2. Cell culture and transfection
HEK293T cells were routinely maintained in DMEM Glutamax
(Invitrogen) supplemented with 10% fetal bovine serum and100 U/ml of penicillin and 100 lg/ml streptomycin sulphate in
5% CO2 at 37 C. Cells were seeded at 1  105 cells/ml into 24 well
plates, in the absence of antibiotic and grown for 24 h until they
were 80% conﬂuent. Cells were then transiently transfected with
expression vectors at 1 lg/ll using Fugene (Promega) following
the manufacturer’s instructions with 0.5 lg DNA, 1.5 ll Fugene in
25 ll opti-MEM per well. Confocal visualisation and FACS con-
ﬁrmed transfection and protein expression 24 h after transfection.
2.3. Functional assays
All experiments were carried out in triplicate and independent
experiments were repeated three times. Media were removed from
the wells and cells were washed with PBS. Varying concentrations
of a-MSH (Sigma) and ASIP (93–132-amide mouse, Phoenix pep-
tides) were prepared in serum-free media. 400 ll of serum-free
media containing the relevant concentrations of a-MSH and/or
ASIP were added to each well and cells were incubated at 37 C
for 45 min. Media were then removed and cells were washed care-
fully with PBS. Ice cold lysis buffer (200 ll) was added to each well
and the cells were shaken in plates for 20 min on ice. The contents
of each well were spun at 13000 rpm for 10 min and cAMP was
measured using a colorimetric ELISA from Cell Biolabs Inc. follow-
ing the manufacturer’s instructions. Results were normalised
against total cellular protein content.
2.4. Computer modelling
Computer modelling of the MC1R variants was carried out using
Phyre2 and Wincoot [25,26]. Docking of the MC1R receptor and
ASIP used the Fast-Fourier shape and electrostatic method of Hex
6.3 followed by side-chain energy minimisation and clustering of
resulting complexes [27]. Structural diagrams were prepared using
Molsoft ICM browser (http://www.molsoft.com).
3. Results
Cells transfected with theMC1R-wt gene showed a basal level of
activity producing 10% maximal cAMP (100% maximal response
being the production of 0.95 pmol cAMP per lg protein in these
experiments). The MC1R-wt cells showed a dose response to
increasing concentrations of a-MSH. With increasing concentra-
tions of a-MSH, in the presence of 10 lM ASIP, the MC1R-wt cells
showed a decrease in cAMP production even with the highest con-
centration of a-MSH at 100 lM (Fig. 1A). MC1R-wt cells showed a
dose response to rising concentration of ASIP with decreasing lev-
els of cAMP production (Fig. 1B). In contrast, the MC1RD24 trans-
fected cells showed an elevated level of basal activity (30%
maximal), together with a dose response to a-MSH. The MC1RD24
cells showed an increased level of cAMP on stimulation with
10 lM ASIP (70% maximal) and cAMP production continued to rise
with increasing levels of a-MSH to the maximal response of 100%
with cells producing 0.95 pmol cAMP per lg protein (Fig. 1A). Con-
trary to expectations, MC1RD24 cells showed a dose response to
increasing concentrations of ASIP with increasing cAMP production
(Fig. 1B). These results show that a-MSH is an agonist for both
MC1R variants but that ASIP, whilst being an inverse agonist for
MC1R-wt, is actually an agonist for MC1RD24.
4. Discussion
During basal activity, GPCRs are in equilibrium between R
(inactive) and R⁄ (active) states. Agonists bind to the receptor
and stabilise the R⁄ conformation leading to full activation of a
signalling pathway whereas inverse agonists bind to the receptor
Fig. 1. Functional coupling of MC1R-wt and MC1RD24 with a-MSH and ASIP. (A) Changes to intracellular levels of cAMP in response to a-MSH in MC1R-wt and MC1RD24
transfected into HEK293T cells with and without 10000 nM ASIP. (B) Changes to intracellular levels of cAMP in response to ASIP in MC1R-wt and MC1RD24. Values on the y
axis represent basal levels of activity in the absence of ligand. Data points show means of triplicates of typical dose response curve determination experiments. Error bars
indicate standard error of the mean.
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activity. Interestingly, it has been shown that inverse agonists are
more stabilising whereas agonists induce more ﬂexibility [28]. In
constitutively active receptors, the equilibrium between R and R⁄
is moved so that receptors are more often in the R⁄ state [29–
33]. Many mutations leading to constitutive activity disrupt non-
covalent intramolecular interactions, altering the conformation
and local dynamics and binding characteristics of ligand-binding
pockets, and areas distal to such sites. It also seems likely that
some mutations leading to constitutive activation mimic the active
conformation stabilised by agonists of the wildtype receptor. How-
ever, it is also likely that there is more than one conformation that
can activate a G protein. The receptor may have a new and com-
pletely different active conformation that binds to the intracellular
effector in a different and possibly more effective way [34,35].
MC1Rs have a ligand binding pocket located below the plasma
membrane to which several transmembrane helices (TMs) contrib-
ute [36]. There are three residues in particular, located deep in the
pocket, which are important for ligand binding and which are
highly conserved in all melanocortin receptors. These residues
are E92, D117 and D121 (mouse numbering) and they contribute
to a highly charged, acidic region involved in ligand binding. The
MC1R agonist a-MSH contains the highly conserved HFRW
sequence. Truncation and mutational studies have shown this to
be the minimal sequence required for binding and activation of
the MC1R [36]. The His residue of this motif seems to be important
for stabilising the ligand–receptor complex and its ring formation
permits conformational change to take place which is required
for signal transduction. The neighbouring Phe residue also contrib-
utes to a stable complex through a hydrophobic aromatic networkat the ligand and receptor interface. The Arg residue is essential for
activation and it is postulated that it interacts with E92, D117 and
D121 acidic cluster on the receptor. Mutational studies have also
shown that the aromatic nature of the Trp residue plays an essen-
tial role in the interaction between a-MSH and the MC1R [37,38].
Analysis of GPCR structures indicate that TM3 acts as an impor-
tant structural and functional ‘hub’ through contact with four other
helices [34,35]. During activation, agonist binding generally
induces a 2 Å shift of TM3 towards the extracellular side of the
receptor. This movement alters the position of the highly con-
served DRY motif of TM3 which, after activation, interacts with
the heterotrimeric G protein subunit on the cytosolic side of the
receptor [39,40]. It is predicted that ligand binding provokes this
movement of TM3 and it is likely that any mutations which alter
its interactions are likely to affect activity.
A number of mutations on the MC1R are associated with
melanism, for example the E92K mutation found in mice, chicken,
Japanese quail and the bananaquit [41–44]. In both the mouse and
chicken, this mutation is known to lead to a constitutively active
receptor [41,45]. Mutagenesis studies on the E92 position conﬁrm
that a change from an acidic to a basic amino acid, either Lys or
Arg, leads to constitutive activity. Binding studies show however
that the E92K reduces ligand binding [21]. It therefore seems likely
that E92, D117 and D121 are in close proximity, but that they con-
tribute to electrostatic repulsion between TM2 and TM3 (Figs. 2
and 3D and E). The introduction of a basic residue could reduce this
repulsion and so alter the overall structure of the receptor, which
might then lead to activation. Similarly, the C125R mutation
associated with constitutive activation and melanism in the fox
would introduce a positive charge and is likely to have a similar
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ciated with constitutive activity and melanism in mice and pigs,
which introduce a Pro, would likely modify the TM positions and
again the effect would be transmitted along the TM3 [41,47]. Thus,
it seems likely that the effect of the E92K, C125R, L98P and L99P
mutations are mimicking the action of the Arg residue of a-MSH
[21]. Studies on the E92K mutation show that the active conforma-
tion induced by ligand binding is distinct from that induced by the
mutation and that the extracellular loop one (ECL1) is involved inFig. 2. Schematic representations of MC1R-wt and MC1RD24 based on Phyre2 and Hex6
light grey circles. (A) Predicted structure of the MC1R-wt showing the eight amino acids
D114 and D118, thought to be important in ligand binding are highlighted with bold ou
lettering. (B) Predicted structure of the MC1RD24 showing a shortened extracellular lo
outline is the E99 of the wildtype relocated to the helix.maintaining the active conformation [48]. The effects of these
mutations may transmit a conformational change along the TM2/
TM3 bundle and ultimately can be envisaged to transmit a struc-
tural signal to the intracellular side of the receptor and in this
way affect G protein speciﬁcity, turnover and/or binding energies
[21].
MC1Rs are unusual in having both endogenous agonist and
inverse agonists. ASIP, which normally functions as an inverse ago-
nist, is much larger and structurally very different to a-MSH. Three.12 computer programmes. Amino acid residues that form b-strands are shown as
(SNALETTI) deleted in the MC1RD24 as dark grey circles with white lettering. E91,
tline. The highly conserved DRY motif of TM3 is shown as black circles with white
op 1 (ECL1) compared with the wildtype receptor. The E91 highlighted with bold
Fig. 3. Computer models of MC1R-wt and MC1RD24. (A) Side view of the MC1R-wt and MC1RD24. (B) MC1R-wt and MC1RD24 superimposed on each other. (C) Extracellular
view of the predicted binding pocket showing TMs. (D) Extracellular view of the predicted binding pockets with E91, D114, D118 and melanic equivalents highlighted. (E)
Extracellular view of binding pockets with Connolly surface shown. (F and G) MC1R-wt and MC1RD24 with ASIP, showing ASIP C-terminal loop and MC1R ECL1. G also shows
the RFF motif in the active loop of ASIP as wire representation.
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loop, the active loop and the N-terminal loop. The active loop
contains the highly conserved RFF motif which is essential in
recognition, binding and inverse agonist function and makes directcontact with the receptor in the transmembrane pocket [49–51].
The site of contact is thought to be partially overlapping the site
for a-MSH [52,53]. The action of RFF is thought to mimic the action
of the HFRW sequence of a-MSH. Interestingly, the partial
Fig. 3 (continued)
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but as an agonist [54]. Similar short peptides are also agonists to
MC4R [55]. All three loops of ASIP are required for full function
as an inverse agonist, but studies have shown that chimeras lack-
ing the C-terminal loop have reduced binding afﬁnities and most
remarkably functioned as agonists [56]. This suggests that the
C-terminal loop is essential for function as an inverse agonist. It
has been shown that the C-terminal loop forms a contact point
with ECL1 of the MC1R (Fig. 3). Speciﬁcally, the LVARAA sequence
of human MC1R and VLSLN of ASIP form hydrophobic interactions
[56]. It has been suggested that with no stabilisation from interac-
tions of the C-terminal loop, the RFF active domain relocates to the
same position as the HFRWmotif and thus activates the receptor in
a similar way to a-MSH [52]. This relocation may be occurring on
the MC1RD24 as depicted in Fig. 4.Computer modelling by Phyre2 matches the squirrel MC1R
sequence to the adenosine a2a receptor (PDB id: 3EML) with 85%
coverage and produces a structural model at high conﬁdence level.
This model predicts that the SNALETTI sequence in the MC1R-wt is
in TM2 and predicts that deletion of SNALETTI from MC1RD24
causes the FLLLEVGALA sequence from wildtype ECL1 to be incor-
porated into TM2 leading to a truncated ECL1 in the mutant
(Fig. 2). Given the ﬁnding that ECL1 is vital for the ASIP to act as
an inverse agonist and that ASIP with no C-terminus loop acts as
an agonist, it seems likely that the shorter ECL1 of MC1RD24 is
preventing ASIP from inactivating the receptor and instead the
ASIP is able to bind to the same region as the a-MSH and activate
the receptor (Figs. 3 and 4). Interestingly, the melanic jaguar and
melanic jaguarundis both have deletions in this region of the
MC1R (Table 1) [57]. Although these deletions fall in slightly
Fig. 4. Schematic representation of ASIP-MC1R-wt and ASIP-MC1RD24 interactions. C = C-terminal loop, A = Active loop and N = N-terminal loop of ASIP. (A) Predicted
hydrophobic interactions between the C-terminal loop of ASIP and ECL1 of MC1R-wt are shown as black circles. (B) Predicted relocation of ASIP when interacting with
MC1RD24 leading to activation of the receptor adapted from [56].
Table 1
Alignment of amino acids from the MC1R of wildtype (accession number EU604830.3) and melanic (accession number EU604831.2) squirrel, wildtype (accession number
AY237396) and melanic (accession number AY237397) jaguar and wildtype (accession number AY237399) and melanic (accession number AY237398) jaguarundis. Numbering is
according to squirrel MC1R-wt. Deleted amino acids are shown as black rectangles. Dashes represent consensus with the wildtype squirrel sequence. Coloured blocks indicate
amino acids predicted by computer modelling to be in extracellular loop 1.
Fig. 5. Schematic representation of TM2, TM3 and ECL1 from the MC1R of wildtype and melanic squirrel, jaguar and jaguarundis. Amino acids that form part of b-pleated
sheets are shown as grey circles. Hydrophobic amino acids are shown as circles with black outlines.
H.R. McRobie et al. / FEBS Letters 588 (2014) 2335–2343 2341different regions, computer models predict that the effects on ECL1
are similar (Fig. 5). Indeed in all three species, ECL1 contains a sec-
tion of b-strand and hydrophobic residues important for inverse
agonist activity in the wildtype. Fig. 5 shows that all ECL1s are
shortened in the melanic phenotypes with no b-strand and fewer
hydrophobic residues. Further studies could determine whetherthese deletions are having similar effects to those found in the
squirrel, leading to changes in agonist and inverse agonist activity
and a higher level of basal activity. We constructed two new
mutants to investigate the effects of deletions in the MC1R. The
MC1RD6 mutant had two amino acids deleted (S87 and N88)
and MC1RD12 had four amino acids deleted (S87, N88, A89 and
2342 H.R. McRobie et al. / FEBS Letters 588 (2014) 2335–2343L90). In both cases the deletions abolished receptor function (data
not shown). Further mutational studies on the MC1R and/or ASIP
may determine the nature of the interactions between these mol-
ecules and reveal which residues are involved when ASIP acts as an
inverse agonist and which interactions occur when it acts as an
agonist.
There are a number of ways the eight amino acids deletion in
the MC1RD24 could be altering the function of the receptor. Firstly,
the wildtype and mutant TM2s differ substantially and it seems
likely that there will be different packing of TM2 and TM3 between
the two cases. It may be hypothesised that TM2 differences and
ECL1 shortening could lead to an upward shift of the TM2-TM3
bundle towards the extracellular side thus mimicking the effect
of agonist binding, creating the upward movement observed in
active receptors. Secondly, the E91 of the squirrel MC1R-wt (E92
equivalent) is deleted which may, as previously noted, be involved
in repulsion between TM2 and TM3 in the wildtype. With this
repulsion removed, TM2 and TM3 could be more closely associ-
ated. Interestingly, however, models predict an E in position 91
in both cases where E99 is relocated into the pocket in the
MC1RD24 (Figs. 2 and 3D and E). This replacement could account
for the MC1RD24 still being responsive to a-MSH (unlike in the
MC1RD6 and MC1RD12 cases). It is likely that the E91 will be dif-
ferently positioned in each case which could alter basal activity
and could also contribute to an altered interaction with ASIP.
Thirdly, with fewer amino acids to contribute to stability and an
altered arrangement, the MC1RD24 receptor may be more ﬂexible
than its wildtype counterpart and more likely to be in the R⁄ state.
Indeed, models predict that N88 of SNALETTI, which is deleted in
the MC1RD24, forms a hydrogen bond with S124 of TM3 in the
MC1R-wt. This would be consistent with the ﬁnding that the
MC1RD24 has a high level of activity but is also still responsive
to ligands, possibly interacting normally with the remaining unaf-
fected loops. Fourthly, the deleted amino acids may have the oppo-
site effect, creating a more stable receptor with an altered
architecture and a permanently enlarged binding region for the G
protein so that it is more often in the R⁄ state. The alteration in
the overall structure of the receptor could be leading to biased sig-
nalling. Future experiments measuring b-arrestin recruitment and
phosphorylation of extracellular signal regulated kinases (ERK)
could establish whether the active conformations of MC1R-wt
and MC1RD24 have similar characteristics or whether active con-
formations of each lead to different downstream signalling.
These experiments in transfected cells with ASIP [93–132] show
that the MC1R-wt behaves as a carefully balanced switch capable
of activation by a-MSH and inactivation by ASIP. In contrast, the
MC1RD24 has lost the ability to act as an effective switch and is
constantly activated, having no ‘‘off switch’’. In native tissue there
may be differences in G protein to receptor coupling, squirrel ASIP
may behave differently to ASIP [93–132] and the presence of
endogenous a-MSH should be considered; however these in vitro
results are consistent with observations of phenotypes. We predict
that MC1R-wt receptors in melanocytes respond to a-MSH and
ASIP producing raised and lowered levels of intracellular cAMP
respectively. This ability to produce varying levels of cAMP ulti-
mately allows the wildtype grey squirrel to produce hairs with
bands of eumelanin and phaeomelanin. In contrast, we predict that
melanocytes with MC1RD24 produce high basal levels of intracel-
lular cAMP which are further raised by both a-MSH and ASIP. We
predict that MC1RD24 melanocytes are unable to produce the
lowered levels of cAMP required to switch from eu- to phaeomel-
anogenesis ultimately resulting in the production of solid eumela-
nin hairs with no banding. Further studies on squirrel melanocytes
and in vivo studies would be needed to conﬁrm these predictions.
We conclude that the eight amino acid deletion of the
MC1RD24 leads to a receptor with high basal activity comparedto the MC1R-wt and that ASIP acts as an inverse agonist to
MC1R-wt but as agonist to MC1R24. This study is the ﬁrst to date
to report that ASIP acts as an agonist to the MC1R in any species.
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